Axon Enterprise, Inc $AXON Stock Holdings Increased by B. Metzler seel. Sohn & Co. AG

Key Points

• B. Metzler seel. Sohn & Co. AG increased its holdings in Axon Enterprise by 28.1% during the first quarter, now owning 7,842 shares valued at approximately $4.12 million.
• Axon Enterprise's recent earnings report showed a significant increase, with earnings per share of $2.12, surpassing estimates by $0.58 and a year-over-year revenue growth of 32.6%.
• Thirteen analysts have rated Axon as a Buy, with a consensus price target of $837.69, indicating positive market sentiment towards the company's future.

B. Metzler seel. Sohn & Co. AG boosted its position in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 28.1% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 7,842 shares of the biotechnology company's stock after buying an additional 1,719 shares during the quarter. B. Metzler seel. Sohn & Co. AG's holdings in Axon Enterprise were worth $4,124,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. LaSalle St. Investment Advisors LLC boosted its stake in Axon Enterprise by 2.1% in the first quarter. LaSalle St. Investment Advisors LLC now owns 777 shares of the biotechnology company's stock valued at $408,000 after acquiring an additional 16 shares during the period. Smartleaf Asset Management LLC boosted its stake in Axon Enterprise by 5.0% in the first quarter. Smartleaf Asset Management LLC now owns 379 shares of the biotechnology company's stock valued at $203,000 after acquiring an additional 18 shares during the period. Pinion Investment Advisors LLC boosted its stake in Axon Enterprise by 3.0% in the first quarter. Pinion Investment Advisors LLC now owns 649 shares of the biotechnology company's stock valued at $341,000 after acquiring an additional 19 shares during the period. Kentucky Retirement Systems boosted its stake in Axon Enterprise by 0.4% in the first quarter. Kentucky Retirement Systems now owns 4,953 shares of the biotechnology company's stock valued at $2,605,000 after acquiring an additional 19 shares during the period. Finally, WCM Investment Management LLC boosted its stake in Axon Enterprise by 0.8% in the first quarter. WCM Investment Management LLC now owns 2,441 shares of the biotechnology company's stock valued at $1,306,000 after acquiring an additional 19 shares during the period. 79.08% of the stock is owned by institutional investors.

Axon Enterprise Price Performance

NASDAQ AXON opened at $769.68 on Thursday. The stock has a market capitalization of $60.42 billion, a P/E ratio of 190.04, a P/E/G ratio of 28.22 and a beta of 1.36. Axon Enterprise, Inc has a 1 year low of $346.71 and a 1 year high of $885.91. The business's fifty day moving average is $772.52 and its two-hundred day moving average is $675.87. The company has a debt-to-equity ratio of 0.63, a quick ratio of 2.71 and a current ratio of 2.95.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its quarterly earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.54 by $0.58. The company had revenue of $668.54 million for the quarter, compared to analysts' expectations of $641.77 million. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The firm's revenue was up 32.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.20 earnings per share. Axon Enterprise has set its FY 2025 guidance at EPS. On average, research analysts forecast that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Axon Enterprise news, insider Jeffrey C. Kunins sold 7,891 shares of the business's stock in a transaction on Thursday, August 14th. The shares were sold at an average price of $750.10, for a total transaction of $5,919,039.10. Following the sale, the insider directly owned 144,538 shares of the company's stock, valued at $108,417,953.80. The trade was a 5.18% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, President Joshua Isner sold 15,919 shares of the business's stock in a transaction on Friday, August 15th. The shares were sold at an average price of $746.26, for a total transaction of $11,879,712.94. Following the sale, the president directly owned 238,379 shares in the company, valued at approximately $177,892,712.54. This trade represents a 6.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 43,790 shares of company stock valued at $33,654,451 in the last three months. Insiders own 4.40% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on AXON shares. Wolfe Research started coverage on Axon Enterprise in a research note on Monday, July 7th. They issued an "outperform" rating for the company. JPMorgan Chase & Co. lifted their target price on Axon Enterprise from $730.00 to $850.00 and gave the company an "overweight" rating in a research note on Thursday, July 17th. Barclays lifted their target price on Axon Enterprise from $726.00 to $735.00 and gave the company an "overweight" rating in a research note on Friday, May 9th. Northland Securities set a $800.00 price objective on Axon Enterprise in a research report on Tuesday, August 5th. Finally, Raymond James Financial reiterated an "outperform" rating and set a $855.00 price objective (up from $645.00) on shares of Axon Enterprise in a research report on Tuesday, August 5th. Thirteen investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $837.69.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.